Roche ($RHHBY) is taking another step toward reducing its focus on gene sequencing by shutting down 454 Life Sciences, a subsidiary in the space it acquired from ...
BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a Roche company, and Roche NimbleGen, both units of Roche Applied Science, have announced a collaboration with Eli Lilly and Company and SeqWright, ...
BRANFORD, Conn.--(BUSINESS WIRE)--454 Life Sciences, a Roche Company, announced today that it has entered an exclusive partnership with DNA Electronics for the development of a low-cost, ...
BRANFORD, Conn. & SAN FRANCISCO--(BUSINESS WIRE)-- 454 Life Sciences, a Roche Company, and Fluidigm Corporation announced today that they have entered a worldwide co-promotional agreement for the ...
(Logo: http://www.newscom.com/cgi-bin/prnh/20090416/IBMLOGO) (Photo: http://photos.prnewswire.com/prnh/20100701/NY29475) (Photo: http://www.newscom.com/cgi-bin/prnh ...
BRANFORD, Conn.--(BUSINESS WIRE)-- 454 Life Sciences, a Roche Company (SWX:RO)(SWX:ROG)(Pink Sheets:RHHBY), announced today the launch and immediate availability of the new GS FLX+ System, an ...
The Roche/454 GS FLX System is based on emulsion PCR [8] and pyrophosphate detection [9] techniques. A library of DNA templates is constructed by a highly efficient DNA amplification method known as ...
A study published this month in the journal Tissue Antigens reports that researchers at Roche Molecular Systems in Pleasanton, CA have used high-throughput sequencing technology from 454 Life Sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback